Skip to main content

Table 3 Adverse events occurring within 28-days of  artesunate-amodiaquine fixed dose combination treatment of uncomplicated falciparum malaria, by Intention-to-treat analysis

From: Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria

Adverse event

Number of patients reporting event n (%)

Pyrexia

25 (8.1)

Cough

21 (6.8)

Asthenia

16 (5.2)

Abdominal pain

13 (4.2)

Upper respiratory tract infection

11 (3.6)

Headache

7 (2.3)

Diarrhoea

7 (2.3)

Decreased appetite

5 (1.6)

Vomiting

4 (1.3)

Gastroenteritis

3 (0.97)

Pruritis

3 (0.97)

Peripheral swelling

3 (0.97)

Pain

2 (0.65)

Oral pain

2 (0.65)

Restlessness

2 (0.65)

Otorrhoea

2 (0.65)

Dysentery

2 (0.65)

Furuncle

2 (0.65)

Abdominal distension

1 (0.32)

Dyspnea

1 (0.32)

Rash

1 (0.32)

Total

136 (44.2)